Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for 5AM Co-Investors IV L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-04-11
Sale
2022-04-13
4:51 pm
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
5AM Ventures IV L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
270,000 $5 $1,350,000 537,301
(Indirect)
View
2020-12-22
Sale
2020-12-28
9:35 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
500,000 $12.82 $6,410,000 181,435
(Indirect)
View
2020-12-14
Sale
2020-12-16
7:15 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
500,000 $12.25 $6,125,915 201,435
(Indirect)
View
2020-11-11
Sale
2020-11-13
8:53 pm
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
ROCKLAGE SCOTT M
10% Owner
800,000 $13.66 $10,928,000 384,496
(Indirect)
View
2020-10-05
Sale
2020-10-07
9:30 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
ROCKLAGE SCOTT M
Former 10% holder
175,000 $25.3 $4,427,500 2,037,654
(Indirect)
View
2020-06-16
Sale
2020-06-18
7:22 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
140,000 $33.3 $4,662,000 313,497
(Indirect)
View
2020-06-11
Sale
2020-06-15
9:12 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
245,000 $28.75 $7,044,412 414,105
(Indirect)
View
2020-05-19
Sale
2020-05-21
9:31 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
255,000 $35.15 $8,963,250 423,905
(Indirect)
View
2019-10-07
Purchase
2019-10-09
6:23 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
333,333 $15 $4,999,995 333,333
(Indirect)
View
2019-06-21
Sale
2019-06-25
7:03 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
Former 10% holder
250,000 $22.2 $5,550,000 94,489
(Indirect)
View
2019-05-28
Purchase
2019-05-28
8:40 pm
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
750,000 $10 $7,500,000 500,000
(Indirect)
View
2019-05-16
Sale
2019-05-20
4:26 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
615,000 $21.47 $13,204,050 221,435
(Indirect)
View
2019-03-18
Sale
2019-03-20
4:48 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
154,839 $24.25 $3,754,954 104,489
(Indirect)
View
2019-01-22
Sale
2019-01-24
7:01 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
262,153 $21.88 $5,734,597 129,483
(Indirect)
View
2018-12-10
Sale
2018-12-12
8:10 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
15,575 $26.01 $405,029 246,035
(Indirect)
View
2018-11-23
Sale
2018-11-27
6:08 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
29,682 $20.04 $594,709 246,658
(Indirect)
View
2018-11-16
Sale
2018-11-20
5:05 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
525,900 $20.2 $10,623,180 247,845
(Indirect)
View
2018-07-20
Purchase
2018-07-20
7:02 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
115,000 $17 $1,955,000 139,969
(Indirect)
View
2017-11-21
Purchase
2017-11-21
7:16 pm
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
654,762 $14 $9,166,668 130,135
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-12-03
Ownership
2021-12-13
4:26 pm
N/A
N/A
Pear Therapeutics Inc. PEAR 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
0 $0 18,631,771
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
2,506,650 $0 333,333
(Indirect)
View
2019-10-02
Ownership
2019-10-02
7:31 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
0 $0 2,519,320
(Indirect)
View
2019-05-28
Conversion
2019-05-28
8:40 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
2,396,191 $0 500,000
(Indirect)
View
2019-05-22
Ownership
2019-05-23
12:21 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
0 $0 2,713,066
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
477,363 $0 486,292
(Indirect)
View
2018-07-20
Conversion
2018-07-20
7:02 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
14,518,556 $0 139,969
(Indirect)
View
2018-07-17
Ownership
2018-07-17
8:14 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
0 $0 3,384,278
(Indirect)
View
2018-04-02
Conversion
2018-04-04
6:41 pm
N/A
N/A
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
5AM Co-Investors IV L.P.
10% Owner
10,784,074 $0 6,722,076
(Indirect)
View
2018-03-27
Ownership
2018-03-27
8:47 pm
N/A
N/A
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
0 $0 6,722,076
(Indirect)
View
2017-11-21
Conversion
2017-11-21
7:16 pm
N/A
N/A
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
21,257,687 $0 130,135
(Indirect)
View
2017-11-16
Ownership
2017-11-16
9:15 pm
N/A
N/A
scPharmaceuticals Inc. SCPH 5AM Partners IV LLC
5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
Schwab Andrew J.
DIEKMAN JOHN D
ROCKLAGE SCOTT M
10% Owner
0 $0 18,659,012
(Indirect)
View